Arterial Network was informed that recently, the annual health industry event sponsored by Zhongkang Information, Xipu will be held in Boao, Hainan. In the same period, the 2018 Xinkang Health Industry Capital Summit will be listed on the theme of “Investment Value in Industry Leap Forwardâ€. 250 major industry executives including enterprises, unicorn companies, top investment institutions, large securities companies, investment banks and high-quality projects at home and abroad attended the event.
During the period, Akang Health was the first batch of innovative demonstration enterprises in the industry's prescription drug supply chain integration service, and participated in the capital summit road show. It was also the only new pharmaceutical circulation enterprise project of 56 quality projects selected by the Capital Summit.
Wang Lizhen, Chairman of Akang Group
Akang Health has more than 13 years of prescription drug management. Since 2014, it has explored opportunities for the development of prescription outflows, from the interpretation of national policies, business model innovation, and corporate diversification, for nearly five years. Taking "the doctor's heart, the medicine of the Buddha, and the medicine that is difficult to find in the world" as the business philosophy, the market will focus on the last mile that maximizes the benefits of the people: grassroots urban and rural areas.
At the same time, in order to help the national medical reform, we always stand at the forefront of the industry's innovation and development, and use the Internet innovation technology to carry out supply chain integration services around the core of chronic diseases, severe diseases and rare diseases, and explore the development of DTP+CDC outside the hospital. The group and the disease are innovative lead-based models such as category planning for the dimension, integrated service model from commodity circulation to disease solution.
As of July 2018, Akon Health has built 17 departments and more than 600 disease treatment solutions in the prescription drug supply chain resource advantage, and built a disease solution solution based on the clinical treatment path. Provide integrated services in the product supply chain to achieve medical + disease + drug pharmacy health management.
Among them, the cloud drug warehouse covers 12,000 actual inventory of all hospitals in China, with a sales rate of 92%. The products cover more than 2,500 domestic and foreign pharmaceutical manufacturers, and currently more than 800 direct industrial enterprises, more than 300 businesses in various regions; The number of end customers reached 180,000; the number of patients with C-terminal chronic diseases reached more than 1 million.
Build a service system based on the disease center and build China's ESI
At this capital summit, Wang Lijun, chairman of Akang Group, took the international standard as the development goal, and proposed that the evolution of the future development of Chinese medicine will be on the “diseaseâ€. The core of prescription outflow will be the rational use of drugs and PBM control fees.
Wang Lijun analyzed the following three main points:
One. The scene of the service of the pharmacy terminal: driven by a single drug sales and sales point to a diversified health service center, the current Internet + pharmacy projects on the market are described in detail: quick order, drug delivery, rehabilitation guidance In the future, the fragmented project will be transformed from a service demand drive into a one-stop convenient and preferential purchase, realizing the financial payment scenario of insurance + insurance.
two. The endogenous demand of a circulating pharmaceutical business enterprise: it is not a drug, but a disease. As an endogenous link between the past and the future, it is inevitable that a rapid transformation is required. The flow of prescription drugs and the development of generic drugs are operated in an orderly manner driven by the favorable policies of the state. They will no longer act as mere drug service providers and obtain operating profits from them. The core of the service system can be firmly established.
three. Extended demand for consumer experience: from drug demand to pharmacy services. Since the national liberalization of doctors, the rise of the Internet medical platform, and the advancement of chronic disease rehabilitation services, all promoted the out-of-hospital circulation of prescription drugs, consumers gradually favored the corresponding drug supply security services, such as providing more reasonable Safe drug use plan; awareness of the promotion of chronic disease regular drug control fees has gradually increased. Therefore, the extended demand for pharmacy services has also deepened with the policy of medical reform.
In view of this, Akang Health proposed the “integrated service model from commodity circulation to disease solution†and actively integrated with international standards to build China's future ESI. Akon Group will be in the 2018 to 2022: supply chain services drive prescription outflows and sinking – with the chronic disease, critically ill, and rare disease supply chain (integration) services as the core, to create a leading company in the pharmaceutical circulation field under the new situation.
From 2023 to 2027: to create a chronic disease critical care system (PBM) with disease as the core - relying on disease types as the core, relying on patient rehabilitation, establishing sound disease data, helping medical insurance and commercial insurance to achieve rational drug use and Control fees, becoming a global leader in drug distribution and drug services;
From 2028 to 2032: to achieve fine medical service management and disease management, become China's ESI - to achieve the full chain of medical + disease + drug + insurance, become the world's largest medical service management and disease health management company.
In the future, Akang Group will take this as its own responsibility and adhere to the business objectives of the company: let the world have no hard-to-find medicines, and it is no longer difficult to find medicines around the world. Developed in cooperation with many industries, focusing on more than 20,000 SKUs in the cloud medicine warehouse, combined with the terminal development of the pharmacy-medical-commercial eco-industrial chain, incubating the pharmacy management service organization with the disease management as the core, promoting the rational use of drugs in China and creating The closed loop of medical + disease + medicine + insurance has become China's ESI.
IOT Smart Ward Nursing System
Smart Ward Nursing System is an indispensable important part in hospital digitization construction, which not only provides the powerful communication among doctors, nurse and patients, but also creatively offers the new functions of voice reminding, information issuing, information collection, multimode connecting data and upload automatically with all testing device in the ward, information process and etc., stretched hospital information system (HIS) to wards. This system has truly achieved a leap of nursing quality besides the greatly decrease of work intensity of nursing staff.
Iot Smart Ward Nursing System,Ward Calling System,Wired Ward Calling System,Smart Wired Ward Calling System
Hunan Eter Medical Co., Ltd. , https://www.eter-tech.com